

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GDP-mannose metabolic process (GO:0019673) | 8.11482577 |
| 2 | DNA strand renaturation (GO:0000733) | 7.77987003 |
| 3 | negative regulation of cell aging (GO:0090344) | 7.13458768 |
| 4 | rRNA methylation (GO:0031167) | 6.39411917 |
| 5 | regulation of skeletal muscle contraction (GO:0014819) | 6.31122228 |
| 6 | meiotic chromosome segregation (GO:0045132) | 5.84347767 |
| 7 | rRNA modification (GO:0000154) | 5.79468710 |
| 8 | lens fiber cell differentiation (GO:0070306) | 5.45075181 |
| 9 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 5.38819737 |
| 10 | regulation of synapse structural plasticity (GO:0051823) | 5.29035867 |
| 11 | positive regulation of protein kinase C signaling (GO:0090037) | 5.21890668 |
| 12 | adenine nucleotide transport (GO:0051503) | 5.03799167 |
| 13 | ribosomal small subunit biogenesis (GO:0042274) | 4.99348325 |
| 14 | purine ribonucleotide transport (GO:0015868) | 4.85849336 |
| 15 | mitotic cell cycle arrest (GO:0071850) | 4.82440349 |
| 16 | UV protection (GO:0009650) | 4.77554722 |
| 17 | nucleoside transmembrane transport (GO:1901642) | 4.69801111 |
| 18 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.54470972 |
| 19 | protein carboxylation (GO:0018214) | 4.54470972 |
| 20 | sensory perception of taste (GO:0050909) | 4.45017577 |
| 21 | DNA replication checkpoint (GO:0000076) | 4.32874796 |
| 22 | regulation of cytokine production involved in inflammatory response (GO:1900015) | 4.32126170 |
| 23 | regulation of cell aging (GO:0090342) | 4.06762939 |
| 24 | nucleotide transmembrane transport (GO:1901679) | 4.02604566 |
| 25 | mannose metabolic process (GO:0006013) | 4.01147711 |
| 26 | behavioral response to nicotine (GO:0035095) | 3.97558901 |
| 27 | positive regulation of heat generation (GO:0031652) | 3.95608481 |
| 28 | tRNA modification (GO:0006400) | 3.93929790 |
| 29 | interferon-gamma production (GO:0032609) | 3.80419680 |
| 30 | purine nucleotide transport (GO:0015865) | 3.73803770 |
| 31 | oligosaccharide catabolic process (GO:0009313) | 3.68650897 |
| 32 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.66856192 |
| 33 | phosphatidylglycerol biosynthetic process (GO:0006655) | 3.66723162 |
| 34 | urinary tract smooth muscle contraction (GO:0014848) | 3.63416515 |
| 35 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.57755967 |
| 36 | protein insertion into membrane (GO:0051205) | 3.55886994 |
| 37 | transepithelial transport (GO:0070633) | 3.51239659 |
| 38 | grooming behavior (GO:0007625) | 3.43172210 |
| 39 | nucleoside transport (GO:0015858) | 3.43100058 |
| 40 | regulation of protein kinase A signaling (GO:0010738) | 3.41377470 |
| 41 | pseudouridine synthesis (GO:0001522) | 3.39206845 |
| 42 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 3.34701583 |
| 43 | negative regulation of tumor necrosis factor production (GO:0032720) | 3.34416834 |
| 44 | diol metabolic process (GO:0034311) | 3.25683328 |
| 45 | melanin biosynthetic process (GO:0042438) | 3.25251546 |
| 46 | detection of light stimulus involved in visual perception (GO:0050908) | 3.23175836 |
| 47 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.23175836 |
| 48 | amino sugar catabolic process (GO:0046348) | 3.23146559 |
| 49 | granulocyte differentiation (GO:0030851) | 3.22930103 |
| 50 | negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556) | 3.22029585 |
| 51 | metallo-sulfur cluster assembly (GO:0031163) | 3.18849207 |
| 52 | iron-sulfur cluster assembly (GO:0016226) | 3.18849207 |
| 53 | sulfur amino acid catabolic process (GO:0000098) | 3.15964536 |
| 54 | folic acid metabolic process (GO:0046655) | 3.14726340 |
| 55 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.12750623 |
| 56 | purine deoxyribonucleotide catabolic process (GO:0009155) | 3.11686019 |
| 57 | response to peptidoglycan (GO:0032494) | 3.09837773 |
| 58 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.07289315 |
| 59 | base-excision repair, AP site formation (GO:0006285) | 3.06623822 |
| 60 | sex determination (GO:0007530) | 3.05999674 |
| 61 | nucleotide salvage (GO:0043173) | 3.05864800 |
| 62 | sphingosine metabolic process (GO:0006670) | 3.04856134 |
| 63 | melanin metabolic process (GO:0006582) | 3.04378695 |
| 64 | cytochrome complex assembly (GO:0017004) | 2.97897298 |
| 65 | folic acid transport (GO:0015884) | 2.96843221 |
| 66 | sphingomyelin metabolic process (GO:0006684) | 2.96527095 |
| 67 | modulation by virus of host process (GO:0019054) | 2.94496488 |
| 68 | histone phosphorylation (GO:0016572) | 2.93478113 |
| 69 | peptidyl-histidine modification (GO:0018202) | 2.93455499 |
| 70 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.92621486 |
| 71 | * purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.86993758 |
| 72 | peristalsis (GO:0030432) | 2.85262443 |
| 73 | regulation of hydrogen peroxide metabolic process (GO:0010310) | 2.83001933 |
| 74 | respiratory chain complex IV assembly (GO:0008535) | 2.82925608 |
| 75 | positive thymic T cell selection (GO:0045059) | 2.80510152 |
| 76 | sialylation (GO:0097503) | 2.80111057 |
| 77 | cellular anion homeostasis (GO:0030002) | 2.78046665 |
| 78 | dolichol-linked oligosaccharide biosynthetic process (GO:0006488) | 2.75054522 |
| 79 | gonadal mesoderm development (GO:0007506) | 2.73698113 |
| 80 | RNA modification (GO:0009451) | 2.70923631 |
| 81 | regulation of phospholipid biosynthetic process (GO:0071071) | 2.68370006 |
| 82 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 cla | 2.67398413 |
| 83 | regulation of heat generation (GO:0031650) | 2.66588810 |
| 84 | negative regulation of interleukin-8 production (GO:0032717) | 2.66045196 |
| 85 | positive regulation of calcium-mediated signaling (GO:0050850) | 2.65980696 |
| 86 | regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803) | 2.64000658 |
| 87 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.62116062 |
| 88 | negative regulation of innate immune response (GO:0045824) | 2.61226510 |
| 89 | estrogen biosynthetic process (GO:0006703) | 2.60967234 |
| 90 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.60307814 |
| 91 | deoxyribonucleotide catabolic process (GO:0009264) | 2.60146154 |
| 92 | tolerance induction (GO:0002507) | 2.59325111 |
| 93 | cellular response to exogenous dsRNA (GO:0071360) | 2.59163916 |
| 94 | secondary metabolite biosynthetic process (GO:0044550) | 2.57415599 |
| 95 | tooth mineralization (GO:0034505) | 2.57018931 |
| 96 | positive regulation of defense response to virus by host (GO:0002230) | 2.55363836 |
| 97 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.54153049 |
| 98 | sphingoid metabolic process (GO:0046519) | 2.53774028 |
| 99 | termination of RNA polymerase III transcription (GO:0006386) | 2.53412327 |
| 100 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.53412327 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VDR_21846776_ChIP-Seq_THP-1_Human | 4.23132693 |
| 2 | * LXR_22292898_ChIP-Seq_THP-1_Human | 2.84179610 |
| 3 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.81674554 |
| 4 | * P68_20966046_ChIP-Seq_HELA_Human | 2.63496654 |
| 5 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.55712083 |
| 6 | MAF_26560356_Chip-Seq_TH2_Human | 2.51222199 |
| 7 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.32341080 |
| 8 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 2.30821918 |
| 9 | * BCL6_27268052_Chip-Seq_Bcells_Human | 2.29605949 |
| 10 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.23980663 |
| 11 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.23395033 |
| 12 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.22116852 |
| 13 | MYC_22102868_ChIP-Seq_BL_Human | 2.16778382 |
| 14 | * BCOR_27268052_Chip-Seq_Bcells_Human | 2.13507902 |
| 15 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 2.12046472 |
| 16 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 2.07480649 |
| 17 | * MAF_26560356_Chip-Seq_TH1_Human | 2.02315652 |
| 18 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.00894624 |
| 19 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.97833225 |
| 20 | * E2F1_20622854_ChIP-Seq_HELA_Human | 1.95773664 |
| 21 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.85060627 |
| 22 | * PHF8_20622854_ChIP-Seq_HELA_Human | 1.82378368 |
| 23 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.77451126 |
| 24 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.74775393 |
| 25 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.73025596 |
| 26 | * CTCF_27219007_Chip-Seq_Bcells_Human | 1.72282119 |
| 27 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.71913547 |
| 28 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.71907395 |
| 29 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.70842888 |
| 30 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.70712124 |
| 31 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.68491612 |
| 32 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.68035973 |
| 33 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.66954094 |
| 34 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.65338114 |
| 35 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.65147890 |
| 36 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.65069431 |
| 37 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.64182232 |
| 38 | * MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.62504917 |
| 39 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.59908954 |
| 40 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.57896454 |
| 41 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.56911181 |
| 42 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.56427731 |
| 43 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.54312756 |
| 44 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.51811150 |
| 45 | * CTCF_21964334_Chip-Seq_Bcells_Human | 1.51700314 |
| 46 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.50669697 |
| 47 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.50510917 |
| 48 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.48438076 |
| 49 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.48211827 |
| 50 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.47403901 |
| 51 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.45044932 |
| 52 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.44852000 |
| 53 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.44129240 |
| 54 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.44017167 |
| 55 | * CTCF_20526341_ChIP-Seq_ESCs_Human | 1.43578734 |
| 56 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.42674722 |
| 57 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.41958973 |
| 58 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.41186952 |
| 59 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.39568520 |
| 60 | * EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.37599847 |
| 61 | SA1_27219007_Chip-Seq_Bcells_Human | 1.37394844 |
| 62 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.37199535 |
| 63 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.35815375 |
| 64 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.34883905 |
| 65 | * RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.32990695 |
| 66 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.32698493 |
| 67 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.29606066 |
| 68 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.28962892 |
| 69 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.28688735 |
| 70 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.28235767 |
| 71 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.26752492 |
| 72 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.26247818 |
| 73 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.24561343 |
| 74 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.23859096 |
| 75 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.23685157 |
| 76 | FLI1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.23509940 |
| 77 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.22935377 |
| 78 | ERA_21632823_ChIP-Seq_H3396_Human | 1.22070289 |
| 79 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.20095941 |
| 80 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19852036 |
| 81 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.19487118 |
| 82 | P300_27268052_Chip-Seq_Bcells_Human | 1.17846239 |
| 83 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.16559346 |
| 84 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.16218616 |
| 85 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15708897 |
| 86 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.15664481 |
| 87 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.15561249 |
| 88 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14874712 |
| 89 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.14217226 |
| 90 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.13387622 |
| 91 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.12101418 |
| 92 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.11771074 |
| 93 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.08714138 |
| 94 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.07661762 |
| 95 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.06796300 |
| 96 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.05579758 |
| 97 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.05069424 |
| 98 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.04557763 |
| 99 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.01702567 |
| 100 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.00506122 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001986_abnormal_taste_sensitivity | 6.25126370 |
| 2 | MP0005171_absent_coat_pigmentation | 6.01319833 |
| 3 | MP0005174_abnormal_tail_pigmentation | 5.87470059 |
| 4 | MP0003136_yellow_coat_color | 5.27814801 |
| 5 | MP0005423_abnormal_somatic_nervous | 4.77069687 |
| 6 | MP0001188_hyperpigmentation | 3.31517563 |
| 7 | MP0005058_abnormal_lysosome_morphology | 2.61300271 |
| 8 | MP0000015_abnormal_ear_pigmentation | 2.49976702 |
| 9 | MP0001968_abnormal_touch/_nociception | 2.32382513 |
| 10 | MP0004381_abnormal_hair_follicle | 2.26925956 |
| 11 | MP0005409_darkened_coat_color | 2.26641235 |
| 12 | MP0003806_abnormal_nucleotide_metabolis | 2.10868652 |
| 13 | MP0001756_abnormal_urination | 2.04692053 |
| 14 | MP0005083_abnormal_biliary_tract | 1.99940012 |
| 15 | MP0008875_abnormal_xenobiotic_pharmacok | 1.97492792 |
| 16 | MP0003453_abnormal_keratinocyte_physiol | 1.84747726 |
| 17 | MP0001873_stomach_inflammation | 1.77798187 |
| 18 | MP0003303_peritoneal_inflammation | 1.69617647 |
| 19 | MP0001502_abnormal_circadian_rhythm | 1.69500836 |
| 20 | MP0002638_abnormal_pupillary_reflex | 1.65129882 |
| 21 | MP0003436_decreased_susceptibility_to | 1.61459821 |
| 22 | MP0003111_abnormal_nucleus_morphology | 1.58747270 |
| 23 | MP0002736_abnormal_nociception_after | 1.54769710 |
| 24 | MP0000685_abnormal_immune_system | 1.50015623 |
| 25 | MP0005671_abnormal_response_to | 1.48673016 |
| 26 | MP0009333_abnormal_splenocyte_physiolog | 1.46535447 |
| 27 | MP0002148_abnormal_hypersensitivity_rea | 1.46378533 |
| 28 | MP0003172_abnormal_lysosome_physiology | 1.40804425 |
| 29 | MP0002254_reproductive_system_inflammat | 1.38008376 |
| 30 | MP0000750_abnormal_muscle_regeneration | 1.36162764 |
| 31 | MP0000538_abnormal_urinary_bladder | 1.33222038 |
| 32 | MP0003693_abnormal_embryo_hatching | 1.26576294 |
| 33 | MP0009840_abnormal_foam_cell | 1.25927563 |
| 34 | MP0002723_abnormal_immune_serum | 1.20088106 |
| 35 | MP0001661_extended_life_span | 1.20057061 |
| 36 | MP0005332_abnormal_amino_acid | 1.20010419 |
| 37 | MP0002277_abnormal_respiratory_mucosa | 1.14131378 |
| 38 | MP0002452_abnormal_antigen_presenting | 1.13952431 |
| 39 | MP0005330_cardiomyopathy | 1.12478138 |
| 40 | MP0005025_abnormal_response_to | 1.12392723 |
| 41 | MP0001800_abnormal_humoral_immune | 1.11913965 |
| 42 | MP0004130_abnormal_muscle_cell | 1.11244222 |
| 43 | MP0000751_myopathy | 1.10956273 |
| 44 | MP0005365_abnormal_bile_salt | 1.10830821 |
| 45 | MP0005387_immune_system_phenotype | 1.08104024 |
| 46 | MP0001790_abnormal_immune_system | 1.08104024 |
| 47 | MP0009278_abnormal_bone_marrow | 1.06553371 |
| 48 | MP0003448_altered_tumor_morphology | 1.05545545 |
| 49 | MP0001835_abnormal_antigen_presentation | 1.04539111 |
| 50 | MP0006082_CNS_inflammation | 1.03005957 |
| 51 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.02257912 |
| 52 | MP0005000_abnormal_immune_tolerance | 1.01132748 |
| 53 | MP0002419_abnormal_innate_immunity | 0.98807705 |
| 54 | MP0004019_abnormal_vitamin_homeostasis | 0.96905973 |
| 55 | MP0001819_abnormal_immune_cell | 0.96441495 |
| 56 | MP0000678_abnormal_parathyroid_gland | 0.96222132 |
| 57 | MP0000013_abnormal_adipose_tissue | 0.96101268 |
| 58 | MP0002420_abnormal_adaptive_immunity | 0.96041097 |
| 59 | MP0005084_abnormal_gallbladder_morpholo | 0.95861346 |
| 60 | MP0002735_abnormal_chemical_nociception | 0.95776433 |
| 61 | MP0001919_abnormal_reproductive_system | 0.91208756 |
| 62 | MP0004043_abnormal_pH_regulation | 0.90503484 |
| 63 | MP0005501_abnormal_skin_physiology | 0.89215453 |
| 64 | MP0006036_abnormal_mitochondrial_physio | 0.86612609 |
| 65 | MP0002933_joint_inflammation | 0.85961644 |
| 66 | MP0002160_abnormal_reproductive_system | 0.85935625 |
| 67 | MP0005410_abnormal_fertilization | 0.85728016 |
| 68 | MP0002405_respiratory_system_inflammati | 0.84242889 |
| 69 | MP0002398_abnormal_bone_marrow | 0.83611446 |
| 70 | MP0000716_abnormal_immune_system | 0.81934871 |
| 71 | MP0002019_abnormal_tumor_incidence | 0.80738864 |
| 72 | MP0002429_abnormal_blood_cell | 0.80401329 |
| 73 | MP0000003_abnormal_adipose_tissue | 0.79522271 |
| 74 | MP0001845_abnormal_inflammatory_respons | 0.79323965 |
| 75 | MP0008469_abnormal_protein_level | 0.79323313 |
| 76 | MP0001765_abnormal_ion_homeostasis | 0.78585624 |
| 77 | MP0010386_abnormal_urinary_bladder | 0.77414372 |
| 78 | MP0003763_abnormal_thymus_physiology | 0.75751170 |
| 79 | MP0004957_abnormal_blastocyst_morpholog | 0.75089320 |
| 80 | MP0003137_abnormal_impulse_conducting | 0.74961551 |
| 81 | MP0000470_abnormal_stomach_morphology | 0.73006391 |
| 82 | MP0000689_abnormal_spleen_morphology | 0.72968209 |
| 83 | MP0000367_abnormal_coat/_hair | 0.72909865 |
| 84 | MP0009643_abnormal_urine_homeostasis | 0.68827916 |
| 85 | MP0002722_abnormal_immune_system | 0.67017915 |
| 86 | MP0005076_abnormal_cell_differentiation | 0.66357597 |
| 87 | MP0005551_abnormal_eye_electrophysiolog | 0.66007165 |
| 88 | MP0009785_altered_susceptibility_to | 0.65003098 |
| 89 | MP0002138_abnormal_hepatobiliary_system | 0.64346074 |
| 90 | MP0000358_abnormal_cell_content/ | 0.63810435 |
| 91 | MP0002136_abnormal_kidney_physiology | 0.63170150 |
| 92 | MP0010155_abnormal_intestine_physiology | 0.62766278 |
| 93 | MP0000703_abnormal_thymus_morphology | 0.62537883 |
| 94 | MP0009931_abnormal_skin_appearance | 0.62330685 |
| 95 | MP0001664_abnormal_digestion | 0.60690416 |
| 96 | MP0003077_abnormal_cell_cycle | 0.60024627 |
| 97 | MP0002075_abnormal_coat/hair_pigmentati | 0.58676789 |
| 98 | MP0000747_muscle_weakness | 0.58394346 |
| 99 | MP0001905_abnormal_dopamine_level | 0.57659996 |
| 100 | MP0005377_hearing/vestibular/ear_phenot | 0.57318867 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Rib fusion (HP:0000902) | 5.85117876 |
| 2 | Testicular atrophy (HP:0000029) | 5.66421243 |
| 3 | Rectal fistula (HP:0100590) | 4.94762475 |
| 4 | Rectovaginal fistula (HP:0000143) | 4.94762475 |
| 5 | Poikiloderma (HP:0001029) | 4.65298614 |
| 6 | Intestinal fistula (HP:0100819) | 4.61940328 |
| 7 | Vaginal fistula (HP:0004320) | 4.54018029 |
| 8 | Annular pancreas (HP:0001734) | 4.47671987 |
| 9 | Attenuation of retinal blood vessels (HP:0007843) | 4.35186313 |
| 10 | Thin bony cortex (HP:0002753) | 4.32150104 |
| 11 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 4.10604419 |
| 12 | Congenital stationary night blindness (HP:0007642) | 4.07988361 |
| 13 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 3.90324100 |
| 14 | Turricephaly (HP:0000262) | 3.85879258 |
| 15 | Dyschromatopsia (HP:0007641) | 3.84441021 |
| 16 | Facial hemangioma (HP:0000329) | 3.77882888 |
| 17 | Renal Fanconi syndrome (HP:0001994) | 3.65643739 |
| 18 | Ulnar bowing (HP:0003031) | 3.62297737 |
| 19 | Squamous cell carcinoma (HP:0002860) | 3.57591669 |
| 20 | Mesangial abnormality (HP:0001966) | 3.54452634 |
| 21 | Abnormality of the intrinsic pathway (HP:0010989) | 3.28829155 |
| 22 | Increased hepatocellular lipid droplets (HP:0006565) | 3.24649853 |
| 23 | Facial diplegia (HP:0001349) | 3.22352190 |
| 24 | Akinesia (HP:0002304) | 3.22349962 |
| 25 | Delayed epiphyseal ossification (HP:0002663) | 3.21871878 |
| 26 | Lipid accumulation in hepatocytes (HP:0006561) | 3.15467206 |
| 27 | Bony spicule pigmentary retinopathy (HP:0007737) | 3.15266890 |
| 28 | Popliteal pterygium (HP:0009756) | 3.09462160 |
| 29 | Patellar aplasia (HP:0006443) | 3.04951236 |
| 30 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 3.04891273 |
| 31 | Coronal craniosynostosis (HP:0004440) | 3.03197837 |
| 32 | Aplasia of the musculature (HP:0100854) | 2.99355370 |
| 33 | Joint hemorrhage (HP:0005261) | 2.94959067 |
| 34 | Abnormal albumin level (HP:0012116) | 2.94880074 |
| 35 | Hypoalbuminemia (HP:0003073) | 2.94880074 |
| 36 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.90388344 |
| 37 | Anteriorly placed anus (HP:0001545) | 2.89178181 |
| 38 | Abnormality of the costochondral junction (HP:0000919) | 2.85598459 |
| 39 | Hemorrhage of the eye (HP:0011885) | 2.84880106 |
| 40 | Prolonged partial thromboplastin time (HP:0003645) | 2.81905437 |
| 41 | Chorioretinal atrophy (HP:0000533) | 2.81113221 |
| 42 | Fetal akinesia sequence (HP:0001989) | 2.79512443 |
| 43 | Joint stiffness (HP:0001387) | 2.77436091 |
| 44 | Amniotic constriction ring (HP:0009775) | 2.76787417 |
| 45 | Abnormality of placental membranes (HP:0011409) | 2.76787417 |
| 46 | Increased intramyocellular lipid droplets (HP:0012240) | 2.71777943 |
| 47 | Absent thumb (HP:0009777) | 2.70614441 |
| 48 | Enlarged epiphyses (HP:0010580) | 2.67679260 |
| 49 | Increased muscle lipid content (HP:0009058) | 2.66917414 |
| 50 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.66509985 |
| 51 | Short chin (HP:0000331) | 2.61188386 |
| 52 | Birth length less than 3rd percentile (HP:0003561) | 2.53160288 |
| 53 | Male infertility (HP:0003251) | 2.51216732 |
| 54 | Hypophosphatemic rickets (HP:0004912) | 2.48710826 |
| 55 | Abnormal drinking behavior (HP:0030082) | 2.46090734 |
| 56 | Polydipsia (HP:0001959) | 2.46090734 |
| 57 | Flat occiput (HP:0005469) | 2.45630296 |
| 58 | Abnormality of glycolipid metabolism (HP:0010969) | 2.33855408 |
| 59 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.33855408 |
| 60 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.33855408 |
| 61 | Premature graying of hair (HP:0002216) | 2.33699318 |
| 62 | Exertional dyspnea (HP:0002875) | 2.28944332 |
| 63 | Basal cell carcinoma (HP:0002671) | 2.26884059 |
| 64 | Capillary hemangiomas (HP:0005306) | 2.25860601 |
| 65 | Choanal stenosis (HP:0000452) | 2.20886481 |
| 66 | Respiratory difficulties (HP:0002880) | 2.20736548 |
| 67 | Widely patent fontanelles and sutures (HP:0004492) | 2.20207075 |
| 68 | Bowed forearm bones (HP:0003956) | 2.19834781 |
| 69 | Bowing of the arm (HP:0006488) | 2.19834781 |
| 70 | Atrioventricular block (HP:0001678) | 2.16978664 |
| 71 | Pendular nystagmus (HP:0012043) | 2.16234626 |
| 72 | Decreased central vision (HP:0007663) | 2.13977545 |
| 73 | Choroideremia (HP:0001139) | 2.12044479 |
| 74 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.08665680 |
| 75 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.08665680 |
| 76 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.08665680 |
| 77 | Abnormal number of erythroid precursors (HP:0012131) | 2.04964818 |
| 78 | Pustule (HP:0200039) | 2.04469997 |
| 79 | Reduced antithrombin III activity (HP:0001976) | 2.03590604 |
| 80 | Abnormality of renal resorption (HP:0011038) | 2.02150290 |
| 81 | Muscle fiber atrophy (HP:0100295) | 2.00177159 |
| 82 | Cheilitis (HP:0100825) | 1.99965258 |
| 83 | Hypoplasia of the pons (HP:0012110) | 1.99708858 |
| 84 | Type 2 muscle fiber atrophy (HP:0003554) | 1.98700760 |
| 85 | Increased cerebral lipofuscin (HP:0011813) | 1.98142244 |
| 86 | Breast hypoplasia (HP:0003187) | 1.97646651 |
| 87 | Recurrent cutaneous fungal infections (HP:0011370) | 1.96560428 |
| 88 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.96560428 |
| 89 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 1.95840284 |
| 90 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.95555994 |
| 91 | Zonular cataract (HP:0010920) | 1.91967610 |
| 92 | Myotonia (HP:0002486) | 1.90914072 |
| 93 | Metaphyseal irregularity (HP:0003025) | 1.89542520 |
| 94 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.88656643 |
| 95 | Mucopolysacchariduria (HP:0008155) | 1.88656643 |
| 96 | Rectal prolapse (HP:0002035) | 1.87934347 |
| 97 | Dysostosis multiplex (HP:0000943) | 1.87842689 |
| 98 | Abnormal trabecular bone morphology (HP:0100671) | 1.86086778 |
| 99 | Polyuria (HP:0000103) | 1.84267540 |
| 100 | Abnormality of the pons (HP:0007361) | 1.83743568 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAPK15 | 7.01596193 |
| 2 | TLK1 | 4.31117015 |
| 3 | BLK | 3.50971041 |
| 4 | WNK4 | 3.27414962 |
| 5 | STK16 | 3.03180089 |
| 6 | TESK2 | 2.82986109 |
| 7 | SMG1 | 2.65884046 |
| 8 | GRK6 | 2.60816865 |
| 9 | NME2 | 2.38153067 |
| 10 | VRK2 | 2.28810599 |
| 11 | SIK2 | 1.89770326 |
| 12 | MAP4K1 | 1.85784979 |
| 13 | MUSK | 1.85452212 |
| 14 | ERN1 | 1.82066094 |
| 15 | TBK1 | 1.61163262 |
| 16 | IRAK2 | 1.54569272 |
| 17 | MAP2K3 | 1.54475341 |
| 18 | TRIB3 | 1.49926479 |
| 19 | TAF1 | 1.49918985 |
| 20 | IRAK3 | 1.47622808 |
| 21 | ACVR1B | 1.46372705 |
| 22 | IKBKB | 1.43776425 |
| 23 | ADRBK2 | 1.37958402 |
| 24 | MAP2K6 | 1.35790419 |
| 25 | ZAP70 | 1.35413663 |
| 26 | CDK4 | 1.33368983 |
| 27 | CSK | 1.30316645 |
| 28 | BCKDK | 1.22420501 |
| 29 | ZAK | 1.18230568 |
| 30 | IKBKE | 1.03999067 |
| 31 | MAPK11 | 1.02484263 |
| 32 | PRKD2 | 1.02058470 |
| 33 | CAMKK2 | 0.99383195 |
| 34 | IRAK4 | 0.97561176 |
| 35 | TXK | 0.97560670 |
| 36 | SIK1 | 0.95245041 |
| 37 | PDPK1 | 0.93441815 |
| 38 | MELK | 0.90966475 |
| 39 | MAPK12 | 0.89137521 |
| 40 | BUB1 | 0.88432229 |
| 41 | PIM2 | 0.87834165 |
| 42 | MAP3K11 | 0.87293184 |
| 43 | NUAK1 | 0.86218917 |
| 44 | SYK | 0.85609606 |
| 45 | MAP3K14 | 0.82063301 |
| 46 | TAOK2 | 0.80957296 |
| 47 | ADRBK1 | 0.79867537 |
| 48 | CCNB1 | 0.79246873 |
| 49 | CDK11A | 0.73887129 |
| 50 | ABL2 | 0.73166217 |
| 51 | RPS6KA6 | 0.72112371 |
| 52 | CDK15 | 0.71697283 |
| 53 | PRKD3 | 0.71063205 |
| 54 | RIPK4 | 0.69974433 |
| 55 | PRPF4B | 0.69748553 |
| 56 | DAPK2 | 0.68322973 |
| 57 | RPS6KC1 | 0.67114758 |
| 58 | RPS6KL1 | 0.67114758 |
| 59 | NEK2 | 0.66191038 |
| 60 | MATK | 0.66124707 |
| 61 | AURKA | 0.65583441 |
| 62 | TGFBR1 | 0.64786605 |
| 63 | LYN | 0.64627514 |
| 64 | CDK18 | 0.62245089 |
| 65 | RPS6KA2 | 0.61718031 |
| 66 | MAPKAPK5 | 0.60833053 |
| 67 | PDK2 | 0.60104002 |
| 68 | STK11 | 0.59136401 |
| 69 | CAMKK1 | 0.57063932 |
| 70 | DYRK1B | 0.57037416 |
| 71 | WNK1 | 0.54853683 |
| 72 | CDC42BPA | 0.54313541 |
| 73 | CHEK2 | 0.54296691 |
| 74 | TNK2 | 0.51320782 |
| 75 | ARAF | 0.50635328 |
| 76 | DAPK1 | 0.49015266 |
| 77 | BTK | 0.48093523 |
| 78 | HIPK2 | 0.47224400 |
| 79 | VRK1 | 0.46715124 |
| 80 | CHUK | 0.45856625 |
| 81 | PRKCQ | 0.45071124 |
| 82 | RPS6KA5 | 0.43394829 |
| 83 | CDK14 | 0.42234282 |
| 84 | CSNK1G3 | 0.40114079 |
| 85 | CDK6 | 0.40108312 |
| 86 | PRKD1 | 0.38439032 |
| 87 | TYK2 | 0.33982386 |
| 88 | MAPK8 | 0.33331885 |
| 89 | CSNK1D | 0.32535677 |
| 90 | DAPK3 | 0.32440390 |
| 91 | EEF2K | 0.31618861 |
| 92 | CAMK1D | 0.30503562 |
| 93 | ATR | 0.29883551 |
| 94 | BMX | 0.29738424 |
| 95 | JAK3 | 0.29606107 |
| 96 | DYRK2 | 0.28708567 |
| 97 | KIT | 0.28091202 |
| 98 | DYRK3 | 0.28034689 |
| 99 | MAP2K2 | 0.25946403 |
| 100 | FES | 0.25766570 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 7.00711443 |
| 2 | Sulfur relay system_Homo sapiens_hsa04122 | 6.68614107 |
| 3 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 4.59566802 |
| 4 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 3.44843966 |
| 5 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 3.27665785 |
| 6 | Other glycan degradation_Homo sapiens_hsa00511 | 2.71788527 |
| 7 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.64021349 |
| 8 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 2.28843558 |
| 9 | Lysosome_Homo sapiens_hsa04142 | 1.93706524 |
| 10 | Ribosome_Homo sapiens_hsa03010 | 1.93645144 |
| 11 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.92071003 |
| 12 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.72736738 |
| 13 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.59871535 |
| 14 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.59546985 |
| 15 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.56970475 |
| 16 | RNA polymerase_Homo sapiens_hsa03020 | 1.56805508 |
| 17 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.56537658 |
| 18 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.50985212 |
| 19 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.48150083 |
| 20 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.23821898 |
| 21 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.19411728 |
| 22 | Base excision repair_Homo sapiens_hsa03410 | 1.03033622 |
| 23 | Homologous recombination_Homo sapiens_hsa03440 | 1.02893500 |
| 24 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.01246492 |
| 25 | Allograft rejection_Homo sapiens_hsa05330 | 0.97874896 |
| 26 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.96883486 |
| 27 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.94490006 |
| 28 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.89165099 |
| 29 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.88776167 |
| 30 | * Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.85755009 |
| 31 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.85710664 |
| 32 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.84927092 |
| 33 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.84741863 |
| 34 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.84264768 |
| 35 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.82498849 |
| 36 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.80942237 |
| 37 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.78879520 |
| 38 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.78269669 |
| 39 | Asthma_Homo sapiens_hsa05310 | 0.78069536 |
| 40 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.76987058 |
| 41 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.75613110 |
| 42 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.74682834 |
| 43 | Parkinsons disease_Homo sapiens_hsa05012 | 0.70899364 |
| 44 | Tuberculosis_Homo sapiens_hsa05152 | 0.68972862 |
| 45 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.68189216 |
| 46 | Bladder cancer_Homo sapiens_hsa05219 | 0.67308514 |
| 47 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.67179223 |
| 48 | Leishmaniasis_Homo sapiens_hsa05140 | 0.63726756 |
| 49 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.61147628 |
| 50 | Taste transduction_Homo sapiens_hsa04742 | 0.61112381 |
| 51 | Circadian rhythm_Homo sapiens_hsa04710 | 0.59547657 |
| 52 | Huntingtons disease_Homo sapiens_hsa05016 | 0.58009252 |
| 53 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.57914365 |
| 54 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.54885999 |
| 55 | Basal transcription factors_Homo sapiens_hsa03022 | 0.53031727 |
| 56 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.49662532 |
| 57 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.49310693 |
| 58 | Alzheimers disease_Homo sapiens_hsa05010 | 0.48064725 |
| 59 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.44668799 |
| 60 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.43365843 |
| 61 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.42739990 |
| 62 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.40861551 |
| 63 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.40603605 |
| 64 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.39195496 |
| 65 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.38895136 |
| 66 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.37139985 |
| 67 | Endocytosis_Homo sapiens_hsa04144 | 0.36140949 |
| 68 | Metabolic pathways_Homo sapiens_hsa01100 | 0.35346374 |
| 69 | Hepatitis C_Homo sapiens_hsa05160 | 0.35208773 |
| 70 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.33206150 |
| 71 | Apoptosis_Homo sapiens_hsa04210 | 0.32934273 |
| 72 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.31303061 |
| 73 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.31077164 |
| 74 | Pertussis_Homo sapiens_hsa05133 | 0.30004051 |
| 75 | Influenza A_Homo sapiens_hsa05164 | 0.29480317 |
| 76 | HTLV-I infection_Homo sapiens_hsa05166 | 0.29201394 |
| 77 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.28986484 |
| 78 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.28408003 |
| 79 | DNA replication_Homo sapiens_hsa03030 | 0.28094624 |
| 80 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.27852473 |
| 81 | Purine metabolism_Homo sapiens_hsa00230 | 0.26294336 |
| 82 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.26122521 |
| 83 | Measles_Homo sapiens_hsa05162 | 0.25807441 |
| 84 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.24980868 |
| 85 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.24310974 |
| 86 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.24208333 |
| 87 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.21757544 |
| 88 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.21059018 |
| 89 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.20250703 |
| 90 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.19811780 |
| 91 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.18227902 |
| 92 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.17391931 |
| 93 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.17387543 |
| 94 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.17142079 |
| 95 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.17081542 |
| 96 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.16794047 |
| 97 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.16246194 |
| 98 | Mineral absorption_Homo sapiens_hsa04978 | 0.15790463 |
| 99 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.15665161 |
| 100 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.15401961 |

